The Monthly Beat

CMHC Newsletter

The Monthly Beat Newsletter features upcoming educational events and educational opportunities, popular blog posts and podcast episodes, faculty and news features, and scientific spotlights on hot topics in cardiorenal metabolic health.

2023 Newsletters

HIGHLIGHT

May is Mental Health Awareness Month

Read Now

HIGHLIGHT

#IAmCardiometabolicMedicine

Read Now

HIGHLIGHT

Women in Medicine

Read Now

HIGHLIGHT

Heart to Heart, Tirzepatide, and More!

Read Now

HIGHLIGHT

FDA News, Partner Spotlight, and More!

Read Now

2022 Newsletters

HIGHLIGHT

Webinar Wednesday, Jessica’s Story, and More!

Read Now

HIGHLIGHT

Contests, Conference Recaps, and More!

Read Now

HIGHLIGHT

CME, Atrial Fibrillation, and More!

Read Now

HIGHLIGHT

Boston, Clinical Cases, CKD, and More!

Read Now

HIGHLIGHT

I am Cardiometabolic Medicine, Clinical Case, and More!

Read Now

HIGHLIGHT

Fourth of July, ADA Sessions, and More!

Read Now

HIGHLIGHT

Policymakers, Women’s Masterclass, and More!

Read Now

HIGHLIGHT

Mental Health Awareness, and More!

Read Now

HIGHLIGHT

Statin Intolerance, Treatment for Heart Failure, and More!

Read Now

HIGHLIGHT

Ethnic & Racial Disparities, Prediabetes, and More!

Read Now

HIGHLIGHT

VTE, Health Tech Wearables, and More!

Read Now

2021 Newsletters

HIGHLIGHT

COVID-19 and the Flu, Youth Obesity, and More!

Read Now

HIGHLIGHT

Recenty published findings on cardiovascular disease, diabetes, and more.

Read Now

HIGHLIGHT

FDA approves PCSK9 inhibitor evolocumab for the treatment of children with heterozygous familial hypercholesterolemia (HeFH) to lower LDL-c levels.

Read Now

HIGHLIGHT

New ESC Guidelines, Myocarditis & COVID-19, and More

Read Now

HIGHLIGHT

Reducing ASCVD Risk, New FDA Approvals & More

Read Now

HIGHLIGHT

Results of STEP trials with semaglutide 2.4mg for obesity management has experts excited about its potential

Read Now

HIGHLIGHT

GALACTIC-HF shows that investigational agent omecamtiv mecarbil works best in heart failure patients with markedly reduced ejection fraction

Read Now

HIGHLIGHT

American Heart Association releases new scientific statement on obesity and cardiovascular disease

Read Now

HIGHLIGHT

Findings from the LOOK AHEAD study indicated that dyslipidemia was associated with a higher risk of CVD outcomes in large samples of obese individuals with T2DM

Read Now

HIGHLIGHT

Entresto, a combination of sacubitril and valsartan, has been FDA approved to directly treat patients with heart failure (HF) with preserved ejection fraction (HFpEF)

Read Now

HIGHLIGHT

Heart failure drug Vericiguat, an orally administered soluble guanylate cyclase (sGC) simulator, receives FDA approval

Read Now

HIGHLIGHT

Happy New Year from the CMHC Team

Read Now

2020 Newsletters

HIGHLIGHT

Polypill with or without Aspirin in Persons without Cardiovascular Disease

Read Now

HIGHLIGHT

FDA approves remdesivir as the first antiviral agent for COVID-19

Read Now

HIGHLIGHT

Drug-Induced Arrhythmias: A Scientific Statement from the American Heart Association

Read Now

HIGHLIGHT

Drug-Induced Arrhythmias: A Scientific Statement from the American Heart Association

Read Now

HIGHLIGHT

Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors

Read Now

HIGHLIGHT

Research review article highlights the status of diabetes and its complications in Latin American population

Read Now

HIGHLIGHT

FDA approves new treatment for HFrEF

Read Now

HIGHLIGHT

New Recommendations for Diabetes Management & Other Hormone Disorders During COVID-19 Pandemic

Read Now

HIGHLIGHT

Hydroxychloroquine-Azithromycin Treatment For COVID-19 May Pose a Risk for Ventricular Arrhythmia

Read Now

HIGHLIGHT

FDA Approves Two Formulations of Bempedoic Acid for LDL-C Reduction

Read Now

HIGHLIGHT

AHA Releases 2020 Heart Disease & Stroke Statistics Update

Read Now

HIGHLIGHT

ADA Releases 2020 Standards of Medical Care in Diabetes

Read Now

2019 Newsletters

HIGHLIGHT

DAPA-HF Study Illustrates Safety and Efficacy of Dapagliflozin In Heart Failure

Read Now

HIGHLIGHT

FDA Approves Dapagliflozin for Heart Failure in Type 2 Diabetes

Read Now

HIGHLIGHT

FDA Expands Recall of Common Blood Pressure Drug

Read Now

HIGHLIGHT

Type 2 Diabetes and Cardiac Remodeling

Read Now

HIGHLIGHT

Study finds no link between SGLT-2 inhibitors and fracture risk in patients with type 2 diabetes

Read Now

HIGHLIGHT

FDA Panel Leans Against Eliminating PAD Device Access

Read Now

HIGHLIGHT

Weight Loss With Metformin Maintained at 15 Years

Read Now

HIGHLIGHT

Harmful Medications Prescribed to Nearly 25% of Patients with HFrEF

Read Now

HIGHLIGHT

REDUCE-IT Trial Presents Updated Findings

Read Now

HIGHLIGHT

ACC & AHA will release comprehensive guidelines for primary CVD prevention at ACC conference

Read Now

HIGHLIGHT

SCIENTIFIC SPOTLIGHT: Role of Real-World Data on Treatment of T2DM

Read Now

HIGHLIGHT

NEWEST PROJECT: Prior Authorization for Access Resource Center

Read Now

2018 Newsletters

HIGHLIGHT

MOMENT WITH A MEMBER: Keith C. Ferdinand, MD, FACC, FAHA

Read Now

HIGHLIGHT

BOSTON HIGHLIGHTS: Read Press Release

Read Now

HIGHLIGHT

CLINICALLY CURRENT CME: Access Your Online Education

Read Now

HIGHLIGHT

SCIENTIFIC SPOTLIGHT: Meta-Analysis Reports Aggressive LDL-C Lowering Reduces Cardiovascular Risk

Read Now

HIGHLIGHT

EVENT ANNOUNCEMENTS: Small Group Workshops

Read Now

HIGHLIGHT

POPULAR PODCAST: Joel Khan, MD

Read Now

HIGHLIGHT

CLINICAL CASE CHALLENGE: Test Your Knowledge

Read Now

HIGHLIGHT

FACULTY FORUM: CMHC faculty member Stephen Devries, MD

Read Now

HIGHLIGHT

BEST BLOG: Fasting Diets Reduce Risk Factors For CVD

Read Now

HIGHLIGHT

UPCOMING PROJECTS: The Cardiometabolic Chronicle

Read Now

HIGHLIGHT

FEATURED ARTICLE: The Reality of Women and Cardiometabolic Disease

Read Now

The Monthly Beat

CMHC Newsletter

The Monthly Beat Newsletter features upcoming educational events and educational opportunities, popular blog posts and podcast episodes, faculty and news features, and scientific spotlights on hot topics in cardiorenal metabolic health.

2023 Newsletters

2022 Newsletters

2021 Newsletters

2020 Newsletters

2019 Newsletters

2018 Newsletters

Industry Resources

See All Publications

Explore On Demand Content

Subscribe

QUICK LINKS

Professional Education

Industry Resources